Topics

Evox Therapeutics and Takeda sign multitarget rare disease collaboration

11:35 EDT 26 Mar 2020 | Manufacturing Chemist

Collaboration focuses on developing novel protein replacement and mRNA therapies and explores the targeted delivery of these payloads using Evox’s proprietary exosome technology

Original Article: Evox Therapeutics and Takeda sign multitarget rare disease collaboration

NEXT ARTICLE

More From BioPortfolio on "Evox Therapeutics and Takeda sign multitarget rare disease collaboration"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...